Cooper Companies (NASDAQ:COO) Sees Unusually-High Trading Volume

The Cooper Companies, Inc. (NASDAQ:COO) shares saw an uptick in trading volume on Monday . 683,684 shares traded hands during mid-day trading, a decline of 38% from the previous session’s volume of 1,107,556 shares.The stock last traded at $92.48 and had previously closed at $93.13.

Analysts Set New Price Targets

Several research analysts have commented on COO shares. Piper Sandler reissued an “overweight” rating and issued a $115.00 price objective on shares of Cooper Companies in a research report on Wednesday, July 3rd. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, May 31st. Robert W. Baird upped their price target on Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a report on Friday, May 31st. Finally, Jefferies Financial Group raised shares of Cooper Companies from a “hold” rating to a “buy” rating and increased their price objective for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.78.

Cooper Companies Stock Up 1.1 %

The firm has a fifty day simple moving average of $90.90 and a 200-day simple moving average of $94.02. The company has a market capitalization of $18.32 billion, a PE ratio of 54.11, a P/E/G ratio of 2.34 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.14 and a current ratio of 1.95.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The business had revenue of $942.60 million during the quarter, compared to analyst estimates of $948.07 million. During the same quarter in the previous year, the firm earned $0.77 earnings per share. The business’s revenue was up 7.4% compared to the same quarter last year. Equities research analysts anticipate that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Cooper Companies

Institutional investors have recently modified their holdings of the stock. Treasurer of the State of North Carolina lifted its stake in Cooper Companies by 0.9% during the fourth quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock worth $8,652,000 after purchasing an additional 212 shares during the last quarter. Hsbc Holdings PLC boosted its holdings in shares of Cooper Companies by 55.3% in the 4th quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock valued at $33,188,000 after buying an additional 31,234 shares during the period. Quantbot Technologies LP acquired a new position in shares of Cooper Companies in the 1st quarter valued at about $2,211,000. Whittier Trust Co. grew its position in shares of Cooper Companies by 298.9% during the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock valued at $1,211,000 after buying an additional 8,947 shares during the last quarter. Finally, Gulf International Bank UK Ltd raised its stake in Cooper Companies by 300.0% during the first quarter. Gulf International Bank UK Ltd now owns 17,148 shares of the medical device company’s stock worth $1,739,000 after acquiring an additional 12,861 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.